Bliss GVS Pharma Limited (BLISSGVS) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE416D01022
Key metrics
- Market Cap
- ₹6,700 Cr
- P/E Ratio
- 50.07
- EPS
- 12.58
- Book Value
- 116.44
- P/B Ratio
- 5.27
- ROE
- 10.48%
- ROCE
- 12.69%
- Debt / Equity
- 0.02
- Net Margin
- 14.03%
- Revenue Growth
- 14.82%
- Profit Growth
- 53.18%
- Dividend Yield
- 0.32%
- 52W High
- ₹635.00
- 52W Low
- ₹118.00
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Bliss GVS Pharma Limited
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 1,033
- Promoter Holding
- 57.48%
The full Bliss GVS Pharma Limited analysis
Create a free account to open the complete BLISSGVS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.